1. Chaput JP, Despres JP, Bouchard C, Tremblay A (2007) Association of sleep
duration with type 2 diabetes and impaired glucose tolerance. Diabetologia 50:
2298–2304.
2. Gangwisch JE, Heymsfield SB, Boden-Albala B, Buijs RM, Kreier F, et al.
(2007) Sleep duration as a risk factor for diabetes incidence in a large US sample.
Sleep 30: 1667–1673.
3. Scheer FAJL, Hilton MF, Mantzoros CS, Shea SA (2009) Adverse metabolic
and cardiovascular consequences of circadian misalignment. Proc Natl Acad Sci
USA 106: 4453–4458.
4. Karlsson B, Alfredsson L, Knutsson A, Andersson E, Toren K (2005) Total
mortality and cause-specific mortality of Swedish shift- and dayworkers in the
pulp and paper industry in 1952–2001. Scand J Work Environ Health 31:
30–35.
5. Karlsson B, Knutsson A, Lindahl B (2001) Is there an association between shift
work and having a metabolic syndrome? Results from a population based survey
of 27,485 people. Occup Environ Med 58: 747–752.
6. Maury E, Moynihan Ramsey K, Bass J (2010) Circadian rhythms and metabolic
syndrome: from experimental genetics to human disease. Circ Res 106:
447–462.
7. Marcheva B, Moynihan Ramsey K, Buhr ED, Kobayashi Y, Su H, et al. (2010)
Disruption of the Clock components CLOCK and BMAL1 leads to
hypoinsulinaemia and diabetes. Nature 466: 627–631.
8. Prokopenko I, Langenberg C, Florez JC, Saxena R, Soranzo N, et al. (2009)
Variants in MTNR1B influence fasting glucose levels. Nat Genet 41: 77–81.
9. Dupuis J, Langenberg C, Prokopenko I, Saxena R, Soranzo N, et al. (2010) New
genetic loci implicated in fasting glucose homeostasis and their impact on type 2
diabetes risk. Nat Genet 42: 105–119.
10. Below JE, Gamazon ER, Morrison JV, Konkashbaev A, Pluzhnikov A, et al.
(2011) Genome-wide association and meta-analysis in populations from Starr
County, Texas, and Mexico City identify type 2 diabetes susceptibility loci and
enrichment for expression quantitative trait loci in top signals. Diabetologia 54:
2047–2055.
11. Englund A, Kovanen L, Saarikoski ST, Haukka J, Reunanen A, et al. (2009)
NPAS2 and PER2 are linked to risk factors of the metabolic syndrome.
J Circadian Rhythms 7: 5.
12. Woon PY, Kaisaki PJ, Braganca J, Bihoreau MT, Levy JC, et al. (2007) Aryl
hydrocarbon receptor nuclear translocator-like (BMAL1) is associated with
susceptibility to hypertension and type 2 diabetes. Proc Natl Acad Sci USA 104:
14412–14417.
14. Garaulet M, Corbalan-Tutau D, Madrid JA, Baraza JC, Parnell LD, et al.
(2010) Period2 variants are associated with abdominal obesity, psychobehavioural
factors, and attrition in the dietary treatment of obesity. J Am Diet
Assoc 110: 917–921.
15. Conlon M, Lightfoot N, Kreiger N (2007) Rotating shift work and risk of
prostate cancer. Epidemiology 18: 182–183.
16. Kasper JS, Giovannucci E (2006) A meta-analysis of diabetes mellitus and the
risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 15: 2056–2062.
17. Stevens VL, Ahn J, Sun J, Jacobs EJ, Moore SC, et al. (2010) HNF1B and JAZF1
genes, diabetes, and prostate cancer risk. Prostate 70: 601–607.
18. Meyer TE, Boerwinkle E, Morrison AC, Volcik KA, Sanderson M, et al. (2010)
Diabetes genes and prostate cancer in the Atherosclerosis Risk in Communities
study. Cancer Epidemiol Biomarkers Prev 19: 558–565.
19. Pierce BL, Ahsan H (2010) Genetic susceptibility to type 2 diabetes is associated
with reduced prostate cancer risk. Hum Hered 69: 193–201.
20. Waters KM, Wilkens LR, Monroe KR, Stram DO, Kolonel LN, et al. (2011) No
association of type 2 diabetes risk variants and prostate cancer risk: the
multiethnic cohort and PAGE. Cancer Epidemiol Biomarkers Prev 20:
1979–1981.
21. Kim S-T, Cheng Y, Tsu F-C, Jin T, Kader AK, et al. (2010) Prostate cancer
risk-associated variants reported from genome-wide association studies: metaanalysis
and their contribution to genetic variation. Prostate 70: 1729–1738.
22. Zeggini E, Scott LJ, Saxena R, Voight BF, Marchini JL, et al. (2008) Metaanalysis
of genome-wide association data and large-scale replication identifies
additional susceptibility loci for type 2 diabetes. Nat Genet 40: 638–645.
23. Zhu Y, Stevens RG, Hoffman AE, Fitzgerald LM, Kwon EM, et al. (2009)
Testing the circadian gene hypothesis in prostate cancer: a population-based
case-control study. Cancer Res 69: 9315–9322.
24. Bellary S, O’Hare JP, Raymond NT, Gumber A, Mughal S, et al. (2008)
Enhanced diabetes care to patients of south Asian ethnic origin (the United
Kingdom Asian Diabetes Study): a cluster randomised controlled trial. Lancet
371: 1769–1776.
25. Alberti KG, Zimmet PZ (1998) Definition, diagnosis and classification of
diabetes mellitus and its complications. Part 1: diagnosis and classification of
diabetes mellitus provisional report of a WHO consultation. Diabet Med 15:
539–553.
26. Rees SD, Hydrie MZI, Shera AS, Kumar S, O’Hare JP, et al. (2011) Replication
of thirteen GWA-validated risk variants for type 2 diabetes in Pakistani
populations. Diabetologia 54: 1368–1374.
27. Voight BF, Scott LJ, Steinthorsdottir V, Morris AP, Dina C, et al. (2010) Twelve
type 2 diabetes susceptibility loci identified through large-scale association
analysis. Nat Genet 42: 579–589.
28. Kooner JS, Saleheen D, Sim X, Sehmi J, Zhang W, et al. (2011) Genome-wide
association study in people of South Asian ancestry identifies six novel
susceptibility loci for type 2 diabetes. Nat Genet 43: 984–989.
29. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, et al. (2007)
PLINK: a tool set for whole-genome association and population-based linkage
analyses. Am J Hum Genet 81: 559–575.
30. Zhang EE, Liu Y, Dentin R, Pongsawakul PY, Liu AC, et al. (2010)
Cryptochrome mediates circadian regulation of cAMP signalling and hepatic
gluconeogenesis. Nat Med 16: 1152–1156.
31. Okano S, Hayasaka K, Igarashi M, Iwai H, Togashi Y, et al. (2010) Non-obese
early onset diabetes mellitus in mutant cryptochrome1 transgenic mice. Eur J Clin
Invest 40: 1011–1017.